Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?

Rosj Gallicchio; Sabrina Giacomobono; Daniela Capacchione; Anna Nardelli; Francesco Barbato; Antonio Nappi; Teresa Pellegrino; Giovanni Storto

doi:10.1007/s12020-013-9935-9

Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?

Rosj Gallicchio, Sabrina Giacomobono, Daniela Capacchione, Anna Nardelli, Francesco Barbato, Antonio Nappi, Teresa Pellegrino, Giovanni Storto

IRCCS Centro di Riferimento Oncologico della Basilicata (CROB)

Research output: Contribution to journal › Article › peer-review

Abstract

Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer

Original language	English
Pages (from-to)	426-433
Number of pages	8
Journal	Endocrine
Volume	44
Issue number	2
DOIs	https://doi.org/10.1007/s12020-013-9935-9
Publication status	Published - Oct 2013

Keywords

Differentiated thyroid cancer
Low-risk patients
Microcarcinoma
Radioiodine therapy
Remnant ablation

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s12020-013-9935-9

Cite this

@article{1e02e31858234f658ba0df70df73b61b,

title = "Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?",

abstract = "Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer ",

keywords = "Differentiated thyroid cancer, Low-risk patients, Microcarcinoma, Radioiodine therapy, Remnant ablation",

author = "Rosj Gallicchio and Sabrina Giacomobono and Daniela Capacchione and Anna Nardelli and Francesco Barbato and Antonio Nappi and Teresa Pellegrino and Giovanni Storto",

year = "2013",

month = oct,

doi = "10.1007/s12020-013-9935-9",

language = "English",

volume = "44",

pages = "426--433",

journal = "Endocrine",

issn = "1355-008X",